Literature DB >> 32969265

Benign parotid mass and facial palsy: systematic review.

K E Stewart1, R Bannon1, M Bannister1.   

Abstract

INTRODUCTION: Parotid masses causing facial palsy are highly indicative of malignancy. A significant number of cases describing benign parotid disease causing facial palsy have been reported.
MATERIALS AND METHODS: We performed a systematic review of the literature to establish the aetiology, clinical features, investigations and management undertaken during these presentations to assess how these factors differed from malignant presentations and to establish an evidence-based algorithm for their management.
RESULTS: A total of 85 cases were identified from 78 articles. Cystadenolymphomas were the most common histopathological type (p = 0.034). Mean facial palsy recovery duration in neoplastic aetiology was longer than for infective aetiology (p = 0.033). A significant association existed between uncommon infective organisms and development of facial palsy (p = <0.0001).
CONCLUSION: Uncommon benign aetiologies are associated with facial palsy. Investigations and management should be guided by patients' clinical presentations, avoiding excessive treatment. Complete facial palsy recovery rates are high, although not immediate.

Entities:  

Keywords:  Facial palsy; Lower motor neurone; Parotid disease; Parotid neoplasms

Mesh:

Year:  2020        PMID: 32969265      PMCID: PMC7705150          DOI: 10.1308/rcsann.2020.0194

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  84 in total

Review 1.  Large intraparotid facial nerve schwannoma: case report and review of the literature.

Authors:  N S Salemis; A Karameris; S Gourgiotis; P Stavrinou; K Nazos; P Vlastarakos; E Tsiambas; E Tsohataridis
Journal:  Int J Oral Maxillofac Surg       Date:  2008-03-12       Impact factor: 2.789

2.  Preoperative facial paralysis in malignant parotid tumours.

Authors:  C M Eneroth; L Andreasson; M Beran; A Biörklund; B Carlsöö; B Modalsli; J Olofsson; M Paavolainen; B Toll
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1977       Impact factor: 1.538

3.  Parotid gland enlargement in HIV infection: clinical/imaging findings.

Authors:  J S Chapnik; A M Noyek; B Berris; G Wortzman; A E Simor; J B Houpt; M I Steinhardt
Journal:  J Otolaryngol       Date:  1990-06

4.  Parotitis and facial nerve dysfunction.

Authors:  J C Andrews; E Abemayor; D M Alessi; R F Canalis
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-02

5.  Facial nerve paralysis. A criterion of malignancy in parotid tumors.

Authors:  C M Eneroth
Journal:  Arch Otolaryngol       Date:  1972-04

6.  Spontaneous facial nerve paralysis associated with an ipsilateral benign parotid tumor. Case report.

Authors:  G A Cimorra; V Ferreira; F J Martinez-Tello
Journal:  Plast Reconstr Surg       Date:  1972-11       Impact factor: 4.730

7.  [Infected cystadenolymphoma. A possible reason for clinical and cytologic diagnostic error "carcinoma"].

Authors:  R Chilla; M Droese
Journal:  HNO       Date:  1993-09       Impact factor: 1.284

8.  Sarcoidosis presenting as multiple cranial neuropathies and a parotid mass.

Authors:  R M Boucher; J Grace; D J Java
Journal:  Otolaryngol Head Neck Surg       Date:  1994-11       Impact factor: 3.497

9.  Facial nerve paralysis in the presence of a benign parotid tumor.

Authors:  L Papangelou; K Alkalai; M Kyrillopoulou
Journal:  Arch Otolaryngol       Date:  1982-07

10.  Parotid Abscess with Involvement of Facial Nerve Branches.

Authors:  Adile Ozkan; Ceyda Hayretdag Ors; Sule Kosar; Handan Isin Ozisik Karaman
Journal:  J Coll Physicians Surg Pak       Date:  2015-08       Impact factor: 0.711

View more
  1 in total

1.  Apparent Diffusion Coefficient (ADC) Histogram Analysis in Parotid Gland Tumors: Evaluating a Novel Approach for Differentiation between Benign and Malignant Parotid Lesions Based on Full Histogram Distributions.

Authors:  Tobias Hepp; Wolfgang Wuest; Rafael Heiss; Matthias Stefan May; Markus Kopp; Matthias Wetzl; Christoph Treutlein; Michael Uder; Marco Wiesmueller
Journal:  Diagnostics (Basel)       Date:  2022-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.